Chunghwa Chemical Synthesis & Biotech Co., Ltd. (TPE:1762)
28.75
-0.60 (-2.04%)
Apr 20, 2026, 1:22 PM CST
TPE:1762 Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 216.44 | 222.28 | 269.57 | 300.61 | 195.25 |
Cash & Short-Term Investments | 216.44 | 222.28 | 269.57 | 300.61 | 195.25 |
Cash Growth | -2.63% | -17.54% | -10.33% | 53.96% | 31.37% |
Accounts Receivable | 92.81 | 194.67 | 248.37 | 301.49 | 379.88 |
Other Receivables | 25.01 | 13 | 9 | 10.86 | 16.13 |
Receivables | 117.82 | 207.67 | 257.37 | 312.34 | 396.01 |
Inventory | 717.94 | 969 | 1,211 | 819.95 | 753.85 |
Prepaid Expenses | 6.69 | 42.28 | 49.82 | 16.08 | 11.97 |
Total Current Assets | 1,059 | 1,441 | 1,788 | 1,449 | 1,357 |
Property, Plant & Equipment | 2,061 | 2,199 | 2,292 | 1,964 | 1,868 |
Long-Term Investments | 1,053 | 1,002 | 994.48 | 998.25 | 1,060 |
Other Intangible Assets | 1.54 | 3.77 | 5.56 | 7.53 | 1.8 |
Long-Term Deferred Tax Assets | 52.28 | 35.55 | 20.44 | 20.14 | 24.48 |
Other Long-Term Assets | 90.65 | 80.91 | 71.27 | 125.42 | 69.35 |
Total Assets | 4,317 | 4,763 | 5,172 | 4,564 | 4,381 |
Accounts Payable | 30.25 | 41.44 | 104.36 | 144.33 | 78.77 |
Accrued Expenses | 41.41 | 57.75 | 122.22 | 193.56 | 143.72 |
Short-Term Debt | 200 | 150 | 500 | 100 | 150 |
Current Portion of Leases | 1.78 | 2.91 | 3.36 | 2.54 | 1.32 |
Current Income Taxes Payable | 0.12 | 1.82 | 10.59 | 49.98 | 31.05 |
Current Unearned Revenue | 52.92 | 124.31 | 15.91 | 53.95 | 73.99 |
Other Current Liabilities | 30.23 | 47.06 | 74.97 | 69.83 | 156.34 |
Total Current Liabilities | 356.71 | 425.29 | 831.41 | 614.18 | 635.17 |
Long-Term Debt | 600 | 700 | 700 | 500 | 600 |
Long-Term Leases | 2.79 | 3.98 | 4.47 | 0.72 | 1.02 |
Long-Term Unearned Revenue | 3.5 | 12.74 | 27 | - | - |
Long-Term Deferred Tax Liabilities | 267.02 | 263.79 | 258.54 | 256.22 | 250.3 |
Total Liabilities | 1,230 | 1,406 | 1,821 | 1,371 | 1,486 |
Common Stock | 769.18 | 775.6 | 775.6 | 775.6 | 775.6 |
Additional Paid-In Capital | 331.76 | 334.53 | 334.53 | 334.32 | 334.32 |
Retained Earnings | 2,042 | 2,312 | 2,296 | 2,129 | 1,744 |
Comprehensive Income & Other | -55.83 | -65.17 | -55.48 | -46.05 | 39.76 |
Total Common Equity | 3,087 | 3,357 | 3,350 | 3,193 | 2,894 |
Minority Interest | - | - | - | 0.19 | 0.19 |
Shareholders' Equity | 3,087 | 3,357 | 3,350 | 3,193 | 2,894 |
Total Liabilities & Equity | 4,317 | 4,763 | 5,172 | 4,564 | 4,381 |
Total Debt | 804.57 | 856.89 | 1,208 | 603.26 | 752.34 |
Net Cash (Debt) | -588.14 | -634.61 | -938.26 | -302.65 | -557.09 |
Net Cash Per Share | -10.58 | -11.27 | -12.01 | -3.86 | -7.11 |
Filing Date Shares Outstanding | 76.92 | 77.56 | 77.56 | 77.56 | 77.56 |
Total Common Shares Outstanding | 76.92 | 77.56 | 77.56 | 77.56 | 77.56 |
Working Capital | 702.18 | 1,016 | 956.37 | 834.81 | 721.91 |
Book Value Per Share | 40.14 | 43.28 | 43.20 | 41.17 | 37.31 |
Tangible Book Value | 3,086 | 3,353 | 3,345 | 3,185 | 2,892 |
Tangible Book Value Per Share | 40.12 | 43.23 | 43.12 | 41.07 | 37.29 |
Land | 1,092 | 1,092 | 1,092 | 741.4 | 741.4 |
Buildings | 954.17 | 948.27 | 936.09 | 900.62 | 826.11 |
Machinery | 2,512 | 2,456 | 2,389 | 2,296 | 2,032 |
Construction In Progress | 14.8 | 59.46 | 48.39 | 27.85 | 126.44 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.